1. A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M1 receptor agonist HTL0018318 in patients with mild‐to‐moderate Alzheimer's disease. Issue 1 (23rd February 2022) Authors: Nathan, Pradeep J.; Millais, S. Babli; Godwood, Alex; Dewit, Odile; Cross, David M.; Liptrot, Janet; Ruparelia, Bharat; Jones, Stephen Paul; Bakker, Geor; Maruff, Paul T.; Light, Gregory A.; Brown, Alastair J.H.; Weir, Malcolm Peter; Congreve, Miles; Tasker, Tim Journal: Alzheimer's & dementia Issue: Volume 8:Issue 1(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomised phase IIb study of mavrilimumab, a novel GM–CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis. Issue 6 (17th February 2017) Authors: Burmester, Gerd R; McInnes, Iain B; Kremer, Joel; Miranda, Pedro; Korkosz, Mariusz; Vencovsky, Jiri; Rubbert-Roth, Andrea; Mysler, Eduardo; Sleeman, Matthew A; Godwood, Alex; Sinibaldi, Dominic; Guo, Xiang; White, Wendy I; Wang, Bing; Wu, Chi-Yuan; Ryan, Patricia C; Close, David; Weinblatt, Micha... Journal: Annals of the rheumatic diseases Issue: Volume 76:Issue 6(2017) Page Start: 1020 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis. Issue 1 (27th December 2017) Authors: Weinblatt, Michael E.; McInnes, Iain B.; Kremer, Joel M.; Miranda, Pedro; Vencovsky, Jiri; Guo, Xiang; White, Wendy I.; Ryan, Patricia C.; Godwood, Alex; Albulescu, Marius; Close, David; Burmester, Gerd R. Journal: Arthritis & rheumatology Issue: Volume 70:Issue 1(2018) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Blockade of GM-CSF pathway induced sustained suppression of myeloid and T cell activities in rheumatoid arthritis. (23rd October 2017) Authors: Guo, Xiang; Higgs, Brandon W; Bay-Jensen, Anne-Christine; Wu, Yuling; Karsdal, Morten A; Kuziora, Michael; Godwood, Alex; Close, David; Ryan, Patricia C; Roskos, Lorin K; White, Wendy I Journal: Rheumatology Issue: Volume 57:Number 1(2018) Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of mavrilimumab in Japanese subjects with rheumatoid arthritis: Findings from a Phase IIa study. Issue 1 (January 2015) Authors: Takeuchi, Tsutomu; Tanaka, Yoshiya; Close, David; Godwood, Alex; Wu, Chi-Yuan; Saurigny, Didier Journal: Modern rheumatology Issue: Volume 25:Issue 1(2015) Page Start: 21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis. Issue 9 (12th December 2012) Authors: Burmester, Gerd R; Weinblatt, Michael E; McInnes, Iain B; Porter, Duncan; Barbarash, Olga; Vatutin, Mykola; Szombati, Istvan; Esfandiari, Ehsanollah; Sleeman, Matthew A; Kane, Christopher D; Cavet, Guy; Wang, Bing; Godwood, Alex; Magrini, Fabio Journal: Annals of the rheumatic diseases Issue: Volume 72:Issue 9(2013) Page Start: 1445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Mavrilimumab, a Fully Human Granulocyte–Macrophage Colony‐Stimulating Factor Receptor α Monoclonal Antibody: Long‐Term Safety and Efficacy in Patients With Rheumatoid Arthritis. Issue 5 (31st March 2018) Authors: Burmester, Gerd R.; McInnes, Iain B.; Kremer, Joel M.; Miranda, Pedro; Vencovský, Jiří; Godwood, Alex; Albulescu, Marius; Michaels, M. Alex; Guo, Xiang; Close, David; Weinblatt, Michael Journal: Arthritis & rheumatology Issue: Volume 70:Issue 5(2018) Page Start: 679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P3‐100: CH 1, 2, AND 3 BASAL FOREBRAIN NUCLEI VOLUMES PREDICT FUNCTIONAL SENSITIVITY TO MUSCARINIC M1 RECEPTOR ANTAGONIST BIPERIDEN ON DELAYED WORD RECALL. (1st July 2019) Authors: Nathan, Pradeep J.; Bakker, Geor; Godwood, Alex; Vingerhoets, Claudia; Caan, Matthan; Bloemen, Oswald; Booij, Jan; van Amelsvoort, Therese Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7S(2019)Part 18 Page Start: P968 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pharmacodynamic biomarkers and differential effects of TNF‐ and GM‐CSF‐targeting biologics in rheumatoid arthritis. (24th October 2018) Authors: Guo, Xiang; Wang, Shiliang; Godwood, Alex; Close, David; Ryan, Patricia C.; Roskos, Lorin K.; White, Wendy I. Journal: International journal of rheumatic diseases Issue: Volume 22:Number 4(2019) Page Start: 646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗